NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly.
Assembly of retrovirus particles is promoted by interaction of the Gag polyprotein with RNA. Nonspecific RNA association with the nucleocapsid domain (NC) of Gag induces the dimerization of Gag through protein-protein contacts in the capsid domain (CA), followed by higher order assembly to form the immature virus particle. NMR relaxation studies were conducted to investigate the initial steps of Rous sarcoma virus (RSV) assembly by examining the association with nucleic acid of a fragment of Gag comprising the C-terminal domain of CA (CTD) postulated to mediate Gag dimerization, the spacer region between CA and NC (SP), and NC. This fragment, CTD-SP-NC (residues 394-577), spans the critical SP region and allows assessment of this key Gag-nucleic acid interaction in the context of the Gag polyprotein rather than the isolated domains. Main-chain amide relaxation of CTD-SP-NC was measured in the absence and presence of (GT)(4), an 8-mer DNA oligonucleotide that binds tightly to the polyprotein but is too short to promote Gag dimerization. The results show that the CTD and NC domains tumble independently. In contrast, the two zinc finger domains within NC are rotationally coupled in both the unbound and bound states, even though only the first zinc finger appears to make direct contact with (GT)(4). In addition, the NMR data indicate that SP and flanking residues undergo a conformational exchange process that is slowed in the presence of (GT)(4). This region around SP where relaxation is strongly affected by (GT)(4) binding is nearly identical to the assembly domain defined previously by mutagenesis studies. Other changes in relaxation induced by (GT)(4) implicate conformational perturbations of helices 1 and 4 in CTD. On the basis of the combined data, we propose a model for the promotion of Gag dimerization by RNA association in which NC-RNA binding disrupts an assembly inhibitory, intramolecular interaction involving SP and CTD. Disruption of this intramolecular interaction is proposed to enhance the accessibility of the Gag dimer contact surface and release the assembly domain to promote intermolecular oligomerization.
Taylor
Gwen M
GM
Department of Medicinal Chemistry and Molecular Pharmacology, Markey Center for Structural Biology, and Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.
Ma
Lixin
L
Vogt
Volker M
VM
Post
Carol Beth
CB
D001483:Base Sequence; D001665:Binding Sites; D015683:Gene Products, gag / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*; D008969:Molecular Sequence Data; D019906:Nuclear Magnetic Resonance, Biomolecular; D019251:Nucleocapsid / Q000737:chemistry / Q000378:metabolism; D017433:Protein Structure, Secondary; D012367:RNA, Viral / Q000737:chemistry* / Q000378:metabolism; D052736:Rous sarcoma virus / Q000378:metabolism*
D015683:Gene Products, gag; D012367:RNA, Viral
Cell. 1996 Dec 27;87(7):1285-94
8980234
Structure. 2009 May 13;17(5):737-48
19446529
EMBO J. 1992 Aug;11(8):3059-65
1639074
Biochemistry. 1992 Sep 15;31(36):8571-86
1390643
Biochemistry. 1990 Jan 16;29(2):329-40
2105740
J Am Chem Soc. 2001 Nov 21;123(46):11484-5
11707129
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304
9636143
Protein Sci. 1992 May;1(5):563-74
1304355
Structure. 2000 Jun 15;8(6):617-28
10873863
Science. 1996 Jul 12;273(5272):231-5
8662505
J Magn Reson. 2001 Apr;149(2):204-17
11318619
J Mol Biol. 2000 Feb 18;296(2):633-49
10669613
Biochemistry. 2003 Jan 21;42(2):320-30
12525159
Protein Sci. 1998 Nov;7(11):2265-80
9827993
J Mol Biol. 1995 Dec 8;254(4):523-37
7500330
Curr Biol. 1997 Oct 1;7(10):729-38
9368755
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11090-5
19549863
Science. 1997 Oct 31;278(5339):849-53
9346481
Structure. 2005 Oct;13(10):1521-31
16216583
J Am Chem Soc. 2001 May 2;123(17):3953-9
11457145
J Biomol NMR. 2000 Jan;16(1):23-8
10718609
Protein Sci. 2004 Aug;13(8):2101-7
15238640
Biochemistry. 1997 Jul 22;36(29):8977-91
9220986
Nat Struct Mol Biol. 2005 Aug;12(8):671-7
16041387
J Virol. 1993 Jul;67(7):4027-36
8510214
Protein Sci. 2005 Feb;14(2):375-86
15659370
J Virol. 2002 Nov;76(22):11177-85
12388677
J Mol Biol. 1998 Jun 19;279(4):921-8
9642071
J Virol. 1995 Oct;69(10):6487-97
7666550
J Virol. 2003 Jun;77(12):7058-66
12768025
J Virol. 2008 Jul;82(14):6788-97
18448521
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
J Virol. 1998 Mar;72(3):1902-9
9499042
Biochemistry. 2000 Feb 22;39(7):1604-12
10677209
Cell. 2007 Oct 5;131(1):70-9
17923088
J Virol. 2002 Jun;76(11):5452-62
11991973
J Mol Biol. 2004 Jan 2;335(1):275-82
14659756
J Virol. 1995 Oct;69(10):6430-8
7666544
J Mol Biol. 1998 Jun 12;279(3):633-49
9641983
Nature. 1995 Dec 14;378(6558):743-7
7501025
Biochemistry. 1994 May 17;33(19):5984-6003
7514039
Mol Cell. 2005 Jan 7;17(1):137-43
15629724
J Mol Biol. 1994 Nov 25;244(2):198-223
7966331
J Virol. 2003 Feb;77(3):1772-83
12525611
J Virol. 2004 Sep;78(18):9675-88
15331700
Biochemistry. 1989 Nov 14;28(23):8972-9
2690953
J Mol Biol. 1996 Dec 20;264(5):1117-31
9000634
J Magn Reson. 2000 Nov;147(1):138-46
11042057
J Virol. 2002 Nov;76(22):11729-37
12388733
J Biol Chem. 2008 Nov 14;283(46):32024-33
18772135
Nat Struct Mol Biol. 2005 Aug;12(8):678-82
16041386
J Virol. 2004 Jan;78(1):52-60
14671087
EMBO J. 2007 Apr 18;26(8):2218-26
17396149